Rosemary Feitis Do entered the industry of Internal Medicine Doctors in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.
To acquire more information, please contact Rosemary Feitis by calling (212) 864-4598 during business hours. You can also write to the business’ Single Location at 680 West End Avenue, New York City, New York NY 10025. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Rosemary Feitis Do |
| Representative: | Rosemary Feitis |
| Place of Business: | 680 West End Avenue, New York City, NY 10025 |
| Contact Number: | (212) 864-4598 |
| Type of Service: | Internal Medicine Doctors |
| SIC Number: | 8011 |
| NAICS Number: | 621111 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 2010 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Rosemary Feitis Do is a company operating from New York, New York providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.
With a current employee count of 1 to 4, Rosemary Feitis Do has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Rosemary Feitis at (212) 864-4598 for related queries, or to locate its Single Location using the coordinates 40.793386,-73.974365.
The Single Location can also be found at the street address 680 West End Avenue in New York City, New York 10025 and can be engaged online through the company website at , the company Twitter , and Facebook page .